BioSpace News Archive

Extendicare Inc. announced the results of matters voted on at its annual meeting of shareholders held on May 29, 2023, which included the election as directors of the Company of all of the nominees listed in its management information and proxy circular dated April 17, 2023.

Bridge Biotherapeutics Inc., a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, is scheduled to give a company presentation on Tuesday, June 6 at the 2023 BIO International Convention taking place in Boston, Massachusetts, between June 5 - 8, 2023.